Nano Precision Medical, Inc.
EMERYVILLE, CA · Founded 2009 · CIK 0001600758 · Medtech · Acquired
Miniaturized long-term biopharmaceutical implants for sustained drug delivery
vivani.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $6.6M
- 7 Form D · Feb 2016
- 128 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 16 granted · 24 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2013201420152016
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $2,000,000 | |
| Private capital raised | Form D · SEC | $2,000,000 | |
| Private capital raised | Form D · SEC | $2,000,000 | |
| Private capital raised | Form D · SEC | $5,000,000 | |
| Private capital raised· 1 of 2 same day | Form D · SEC | $100,000 | |
| Private capital raised· 2 of 2 same day | Form D · SEC | $250,000 | |
| Private capital raised | Form D · SEC | $250,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 814 | Siesta Medical, Inc. | — | $1.9M |
| 815 | NeuMoDx Molecular, Inc. | — | $55M |
| 816 | Soliton, Inc. | — | $15M |
| 817 | Nano Precision Medical, Inc. | — | $6.6M |
| 818 | Innoblative Designs | — | $4.4M |
| 819 | ESTABLISHMENT LABS HOLDINGS INC. | — | $56M |
| 820 | TrackX Technology, Inc. | — | $11M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- W. BakerDirector
- W. BAKERDirector
- Kathleen FischerDirector · Executive Officer
- KATHLEEN FISCHERDirector · Executive Officer
- Kathleen FisherExecutive Officer
- Adam MendelsohnDirector · Executive Officer
- Aaron MendelsohnDirector
- AARON MENDELSOHNDirector
- ADAM MENDELSOHNDirector · Executive Officer
- Lily PengDirector · Executive Officer
- LILY PENGDirector · Executive Officer
Patents
- Formulations, Devices And Methods For A GLP-1 Agonistapplication
- Implantable Medical Devices For Extended Release Of Therapeutic Agentsgranted
- Devices And Methods To Improve Bioavailability Of Therapeutic Agentsapplication
- Polymeric Stabilizing Formulationsgranted
- Drug Delivery Devicegranted
- Implantable Medical Devices For Extended Release Of Therapeutic Agentsgranted
- Methods To Control The Rate Of Release Of Therapeutic Agents From Implantable Devicesapplication
- Implant Delivery System With Hydration Promotor Capabilitygranted
- Drug Delivery Devicegranted
- Polymeric Stabilizing Formulationsgranted
- Implantable Drug Delivery Devicegranted
- Implantable Medical Devices For Extended Release Of Therapeutic Agentsgranted
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.